Formulating for the Future of Transplant Patient Therapy
Veloxis is a specialty pharmaceutical company committed to improving the lives of transplant patients. Our unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs.
Veloxis is an international company with headquarters in Hørsholm, Denmark, and a fully owned subsidiary in Edison, New Jersey, USA.
Veloxis is committed to patient access and financial support for kidney transplant patients. Learn more about our prescription cost savings programs, click here
Conference call at 3:00 pm CEST
Please dial in 5-10 minutes prior to the start time using the number / Conference ID below.
Confirmation Code: 4376388
UK: +44(0)20 3427 1909
US: +1646 254 3361
DK: +4532 71 16 59